Cath Lab Market: How Is Coronary Physiology Assessment Changing PCI Decision-Making?

0
256

Coronary physiology-guided percutaneous coronary intervention — using fractional flow reserve or instantaneous wave-free ratio to assess the hemodynamic significance of coronary lesions before stenting — has transformed cath lab practice, with the Cath Lab Market reflecting the commercial adoption of pressure wire technology and non-invasive physiological assessment software that has improved clinical outcomes by avoiding stenting of hemodynamically insignificant lesions.

The landmark DEFER, FAME, and FAME-2 trials established that FFR-guided PCI — deferring revascularization for lesions with FFR above 0.80 — reduces unnecessary stent implantation, procedural complications, and major adverse cardiac events compared to angiography-guided stenting of visually intermediate lesions that FFR assessment reveals as hemodynamically non-significant. FAME-2's demonstration that FFR-guided PCI reduces urgent revascularization compared to medical therapy for hemodynamically significant lesions confirmed both the value of physiological assessment and the benefit of revascularizing truly significant disease.

iFR — instantaneous wave-free ratio measured during the diastolic pressure-free period without adenosine — provides equivalent physiological assessment to adenosine-dependent FFR in the DEFINE-FLAIR and iFR-SWEDEHEART trials while eliminating the adenosine infusion requirement that adds cost, time, and patient discomfort. iFR adoption in clinical practice has been facilitated by the equivalent diagnostic performance without adenosine administration.

Quantitative flow ratio — non-invasive physiological assessment computed from 3D coronary reconstruction of angiographic images without pressure wire — represents the emerging technology enabling physiological assessment of every coronary stenosis from standard angiographic acquisitions, potentially making physiological guidance universally accessible without additional catheter-based measurements.

Do you think AI-computed angiography-based physiology will eventually replace pressure wire-based FFR as the standard physiological assessment in cath labs?

FAQ

What is FFR in cardiac catheterization? Fractional flow reserve is the ratio of maximal coronary blood flow across a stenosis to the theoretical normal flow, measured using a pressure wire with adenosine-induced maximal hyperemia; FFR below 0.80 indicates hemodynamically significant stenosis warranting revascularization.

What is iFR and how does it differ from FFR? iFR measures coronary pressure ratio during the diastolic wave-free period without requiring adenosine administration, providing equivalent physiological stenosis assessment to FFR with greater patient comfort and simplified procedure workflow.

#CathLab #CoronaryPhysiology #FFR #iFR #PCI #InterventionalCardiology

Search
Categories
Read More
Other
Pets Anti Infective Medicine Market Growth Trends Insights and Forecast Outlook to 2034
According to a new report from Intel Market Research, the global Pets Anti Infective Medicine...
By Sharvari Kumbhare 2026-05-13 09:57:47 0 3
Other
Extended Reality XR Hardware Market Analysis: Unlocking Industry Potential
The Extended Reality XR Hardware Market Analysis is undergoing transformative changes as...
By Akanksha Bhoite 2026-01-27 09:25:07 0 291
Art
Circular Fiber Connectors Market: Industry Overview and Long-Term Forecast 2026-2034
The global Circular Fiber Connectors Market, valued at US$ 185 million in 2024, is projected to...
By Prerana Kulkarni 2026-03-04 12:25:57 0 239
Networking
Elderly Care Market Trends, Insights and Future Outlook
  The Elderly Care Market is transforming with the rising demand for advanced healthcare,...
By Harshasharma Harshasharma 2025-11-28 08:43:55 0 714
Other
Global MBE Grade Arsenic Market Growth Drivers and Forecast 2026–2034 at 3.9% CAGR
 According to a new report from Intel Market Research, the global MBE Grade...
By Priya Intel 2026-01-28 09:38:50 0 315